Evidence map›Paper›PMID 41473536›Full record

ArticleBritish journal of biomedical science2025

Epidemiological Analysis of Antinuclear Antibodies Positivity and Pattern Distribution in a Taiwanese Hospital-Based Cohort.

Yu-Wei Tseng, Cheng-Li Lin, Si-Yu Chen, Tze-Kiong Er

Abstract read
In one paragraph

Article in British journal of biomedical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu-Wei TsengDivision of Laboratory Medicine, Asia University Hospital, Asia University, Taichung, Taiwan.
Cheng-Li LinManagement Office for Health Data, China Medical University Hospital, Taichung, Taiwan.
Si-Yu ChenDivision of Laboratory Medicine, Asia University Hospital, Asia University, Taichung, Taiwan.
Tze-Kiong ErDivision of Laboratory Medicine, Asia University Hospital, Asia University, Taichung, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Autoimmune diseases pose an increasing global health burden. The detection of antinuclear antibodies (ANA) via indirect immunofluorescence (IIF) is central to diagnosing systemic autoimmune conditions. This study aimed to assess the prevalence and distribution of ANA patterns in a Taiwanese population. Methods: We conducted a retrospective, cross-sectional study of 8,299 patients who underwent ANA testing at Asia University Hospital between January 2021 and December 2023. ANA patterns were classified based on fluorescence staining characteristics. Demographic variables, including age and gender, were analyzed. Results: ANA positivity was observed in 35.3% of patients. The most frequent pattern was homogeneous (33.0%), followed by speckled (24.1%). Female patients had a significantly higher positivity rate (female-to-male ratio 2.7:1), and the ≥66-year age group accounted for 34.6% of ANA-positive cases. Mixed ANA patterns were identified in 22.8% of ANA-positive patients, with homogeneous-speckled being the most common combination (27.4%). Conclusion: This large-scale study provides valuable epidemiological data on ANA prevalence and pattern distribution in Taiwan. The predominance of homogeneous and speckled patterns, particularly among older female patients, aligns with established trends in autoimmune diseases. The high proportion of mixed ANA patterns suggests the need for further investigation into their clinical significance and diagnostic value.

Indexed as

Antibodies, AntinuclearAutoimmune DiseasesAdolescentAdultAgedAged, 80 and overChildCross-Sectional StudiesFemaleFluorescent Antibody Technique, IndirectHumansMaleMiddle AgedPrevalenceRetrospective StudiesTaiwanAntibodies, AntinuclearANA patternsantinuclear antibodiesautoimmune diseasesindirect immunofluorescenceprevalence

Identifiers

PMID41473536
PMCPMC12745285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.